Prosepe I, Groenwold RHH, Knevel R, Pajouheshnia R, van Geloven N. The disconnect between development and intended use of clinical prediction models for covid-19: a systematic review and real-world data illustration. Front Epidemiol. 2022 Jun;2:899589. doi: 10.3389/fepid.2022.899589
Chung AH, Leisner TM, Dardis GJ, Bivins MM, Keller AL, Parise LV. CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death. Cancer Cell Int. 2019 Feb 4;19(26). doi: 10.1186/s12935-019-0740-2
Hirsch IB, Xu Y, Davis KL, Calingaert B. Patient factors associated with glucagonlike peptide 1 receptor agonist use with and without insulin. Endocr Pract. 2011 Sep 1;17(5):707-16.